Scarica l'app Stockscreener
3.52
2.03%
0.07
Dopo l'orario di chiusura:
3.63
0.11
+3.12%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$3.45
Aprire:
$3.41
Volume 24 ore:
27,502
Relative Volume:
0.40
Capitalizzazione di mercato:
$52.66M
Reddito:
$37.79M
Utile/perdita netta:
$-10.38M
Rapporto P/E:
-4.8219
EPS:
-0.73
Flusso di cassa netto:
$-1.00M
1 W Prestazione:
+0.14%
1M Prestazione:
+0.86%
6M Prestazione:
+55.75%
1 anno Prestazione:
+146.15%
Intervallo 1D:
$3.31
$3.565
Intervallo di 1 settimana:
$3.25
$3.65
Portata 52W:
$1.04
$7.25
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
Nome
Cumberland Pharmaceuticals Inc
Settore
Telefono
615-255-0068
Indirizzo
2525 WEST END AVENUE, NASHVILLE,, TN
Confronta CPIX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
3.52 | 51.62M | 37.79M | -10.38M | -1.00M | -0.73 |
|
ZTS
Zoetis Inc
|
147.38 | 64.91B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.16 | 43.33B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.66 | 42.36B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.38 | 17.72B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
294.28 | 12.42B | 2.99B | 1.21B | 1.13B | 25.06 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2012-11-12 | Reiterato | UBS | Neutral |
| 2011-02-01 | Reiterato | UBS | Neutral |
| 2010-12-16 | Downgrade | UBS | Buy → Neutral |
| 2010-08-17 | Downgrade | Jefferies | Buy → Hold |
| 2010-08-17 | Reiterato | Morgan Joseph | Buy |
| 2010-08-17 | Reiterato | UBS | Buy |
| 2010-05-14 | Reiterato | Morgan Joseph | Buy |
Mostra tutto
Cumberland Pharmaceuticals Inc Borsa (CPIX) Ultime notizie
Does Cumberland Pharmaceuticals Inc. stock perform well during market downturnsEarnings Report Planner For 2025 - jammulinksnews.com
Is it the right time to buy Cumberland Pharmaceuticals Inc. stockChart Pattern Growth Plan For Smart Trading - jammulinksnews.com
What makes Cumberland Pharmaceuticals Inc. stock price move sharplyStock Strategy Trend Scanner To Watch Now - jammulinksnews.com
Understanding Cumberland Pharmaceuticals Inc.’s price movementFree Consistent Income Focused Trade List - Newser
What’s next for Cumberland Pharmaceuticals Inc. stock priceDaily Pattern Analysis with Return Forecast - Newser
Sector ETF performance correlation with Cumberland Pharmaceuticals Inc.Risk Aware Trading Ideas with Alert Levels - Newser
Short interest data insights for Cumberland Pharmaceuticals Inc.Predictive Analytics for Equity Growth Potential - Newser
What data driven models say about Cumberland Pharmaceuticals Inc.’s futureFree Watchlist for Low Risk High Return - Newser
Tools to monitor Cumberland Pharmaceuticals Inc. recovery probabilityYield Curve Outlook and Long-Term Implication Summary - Newser
Using portfolio simulators with Cumberland Pharmaceuticals Inc. includedBuy and Hold Position Summary Review - Newser
How Cumberland Pharmaceuticals Inc. stock performs during market volatilityFree Pattern Detection for Entry Confirmation - Newser
How Efficient Is Cumberland Pharmaceuticals Inc. at Controlling Operating CostsReal Time Alert System for Market Moves - Newser
Why Cumberland Pharmaceuticals Inc. stock attracts strong analyst attentionQuick Profit Setup with Signal Forecast - Newser
What are the technical indicators suggesting about Cumberland Pharmaceuticals Inc.Real Time Guidance For 2025 - jammulinksnews.com
Real time breakdown of Cumberland Pharmaceuticals Inc. stock performanceFree Risk Managed Intraday Trade Alerts - Newser
Cumberland Pharmaceuticals Inc. Stock Performance After Earnings: Historical InsightsDaily Trade Setup Forecast with Confidence - Newser
Key External Factors That Drive Cumberland Pharmaceuticals Inc. Stock Price MovementsRisk Controlled Short Term Trade Plans Published - metal.it
Cumberland Pharmaceuticals Inc. Company Revenue and Profit Trends: A Deep DiveHigh Win Rate Trading Opportunities Detected - metal.it
Cumberland Pharmaceuticals Inc. recovery potential after sell off3-Year Equity Summary With Setup Insights - Newser
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q2 2025 FINANCIAL RESULTS & COMPANY UPDATE - 富途牛牛
Cumberland Pharmaceuticals Sets Q2 Earnings Date: FDA-Approved Drug Portfolio Update Coming August 5 - Stock Titan
MACD Cross Could Confirm Trend in Cumberland Pharmaceuticals Inc.Stock Portfolio Allocation Guidance for Volatile Markets - metal.it
How to recover losses in Cumberland Pharmaceuticals Inc. stockBuy Point Strategy with Profit Protection - Newser
Fibonacci Retracement Aligns with Support in Cumberland Pharmaceuticals Inc.Strong Buy With Technical Confidence Supported - beatles.ru
Traders Watching For Reversal Pattern in Cumberland Pharmaceuticals Inc.Weekly Stock Watch With Growth Focus Expanded - metal.it
Why is Cumberland Pharmaceuticals Inc. stock attracting strong analyst attentionStock Strategy Data Feed With High Returns - jammulinksnews.com
Duchenne Muscular Dystrophy Market to Witness Significant Expansion During the Forecast Period (2025–2034) Amidst Advances in Gene Therapy and Novel Drug Approvals | DelveInsight - GlobeNewswire Inc.
How does Cumberland Pharmaceuticals Inc. generate profit in a changing economyExplosive earnings growth - jammulinksnews.com
Using portfolio simulators with Cumberland Pharmaceuticals Inc. included Predictive System for Long-Term Stock Forecast - Newser
Top chart patterns to watch in Cumberland Pharmaceuticals Inc. Free Smart Allocation Stock Pick Insights - Newser
Should I hold or sell Cumberland Pharmaceuticals Inc. stock in 2025Massive stock growth - jammulinksnews.com
What catalysts could drive Cumberland Pharmaceuticals Inc. stock higher in 2025Get real-time updates on market trends - jammulinksnews.com
What are Cumberland Pharmaceuticals Inc. company’s key revenue driversPowerful market insights - jammulinksnews.com
Is Cumberland Pharmaceuticals Inc. stock overvalued or undervaluedDynamic profit expansion - jammulinksnews.com
Cumberland Pharmaceuticals Inc Azioni (CPIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.87%
0.80%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):